NCT01284673

Brief Summary

Neonatal anoxic-ischaemic enkephalopathy is a dramatic perinatal complication due to brain asphyxia. Neurological and neurosensory sequelae are frequent in survivors, due to neuronal damage and loss. For the moment, only total or partial body hypothermia can partially prevent cell loss. However, no treatment exists to restore neuronal functions. Cord blood stem cells are a promising treatment for the near future. However, before conducting a clinical trial to evaluate the safety and feasibility of autologous cell therapy in neonatal asphyxia, in vitro characterization of the cord blood stem cell in situation of neonatal asphyxia, compared to normal situation, is needed. The primary objective of this study is to characterize cord blood stem cells of neonates with neonatal asphyxia and to compare them with those from healthy newborn. The quantitative and qualitative, functional characterization will insist on cell populations which could potentially participate to neuronal regeneration. Secondary objectives are to assess such characteristics in conditions of cryo-preservation, compared to fresh cell preparation

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

April 16, 2010

Completed
10 months until next milestone

First Posted

Study publicly available on registry

January 27, 2011

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
Last Updated

August 3, 2016

Status Verified

August 1, 2016

Enrollment Period

5.9 years

First QC Date

April 16, 2010

Last Update Submit

August 2, 2016

Conditions

Keywords

Cord blood stemneonatal asphyxia

Outcome Measures

Primary Outcomes (1)

  • The primary objective of this study is to characterize cord blood stem cells of neonates with neonatal asphyxia and to compare them with those from healthy newborn

    The quantitative and qualitative, functional characterization will insist on cell populations which could potentially participate to neuronal regeneration.

    two years

Interventions

The quantitative and qualitative, functional characterization will insist on cell populations which could potentially participate to neuronal regeneration. and assessment such characteristics in conditions of cryo-preservation, compared to fresh cell preparation

Eligibility Criteria

Age1 Minute - 20 Minutes
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • delivery at 37 week or more of pregnancy
  • normal pregnancy and delivery

You may not qualify if:

  • parental refusal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assistance publique Hopitaux de Marseille

Marseille, bouches du Rhone, 13005, France

Location

MeSH Terms

Conditions

Respiratory Distress SyndromeAsphyxia Neonatorum

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration DisordersInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Umberto SIMEONI, MD PhD

    AP-HM

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 16, 2010

First Posted

January 27, 2011

Study Start

April 1, 2010

Primary Completion

March 1, 2016

Study Completion

March 1, 2016

Last Updated

August 3, 2016

Record last verified: 2016-08

Locations